Lawrence is a health economist with more than 18 years of experience conducting applied research on the economic impact of HIV, TB and associated conditions within South Africa and the region. He is currently a Research Associate Professor at the Boston University School of Public Health (Boston, USA) and holds a joint appointment at the University of Witwatersrand (Johannesburg, South Africa). Prior to this he led a growing South African research group as the deputy director and has extensive experience in organizational management, leadership and grant management. Lawrence has training in economics, finance, mathematics, research methodology and behavioral science. He is the principal investigator of a number of research projects and has published widely in peer reviewed publications. He is currently the principal investigator of an NIH K01 award entitled: "Using behavioral economics to improve the uptake of and persistence on pre-exposure prophylaxis in men who have sex with men to prevent HIV infection" and research faculty on Indlela, a Gates funded program to build behavioral economics capacity for HIV in South Africa.
- University of the Witwatersrand, PhD Field of Study: Public Health
- London School of Economics and Political Science, MS
- University of the Witwatersrand, M.Com. Field of Study: Economics
- University of Cape Town, B.Bus.Sci. Field of Study: Economics/Finance
- Published on 7/12/2023
Dovel K, Balakasi K, Hubbard J, Phiri K, Nichols BE, Coates TJ, Kulich M, Chikuse E, Phiri S, Long LC, Hoffman RM, Choko AT. Identifying efficient linkage strategies for men (IDEaL): a study protocol for an individually randomised control trial. BMJ Open. 2023 Jul 12; 13(7):e070896. PMID: 37438067.
- Published on 7/1/2023
Govathson C, Long LC, Russell CA, Moolla A, Pascoe S, Nichols BE. A modelling framework for translating discrete choice experiment results into cost-effectiveness estimates: an application to designing tailored and scalable HIV and contraceptive services for adolescents in Gauteng, South Africa. J Int AIDS Soc. 2023 Jul; 26(7):e26124. PMID: 37463870.
- Published on 4/6/2023
Juntunen A, Scott NA, Kaiser JL, Vian T, Ngoma T, Mataka KK, Bwalya M, Sakanga V, Kalaba D, Biemba G, Rockers PC, Hamer DH, Long LC. A cost description of the setup costs of community-owned maternity waiting homes in rural Zambia. PLOS Glob Public Health. 2023; 3(4):e0000340. PMID: 37022997.
- Published on 3/11/2023
Long LC, Girdwood S, Govender K, Meyer-Rath G, Miot J. Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa. BMC Health Serv Res. 2023 Mar 11; 23(1):240. PMID: 36906559.
- Published on 12/26/2022
Dovel K, Balakasi K, Hubbard J, Phiri K, Nichols B, Coates T, Kulich M, Chikuse E, Phiri S, Long L, Hoffman R, Choko A. Identifying efficient linkage strategies for HIV self-testing (IDEaL): a study protocol for an individually randomized control trial. medRxiiv. 2022.
- Published on 12/22/2022
Pascoe S, Fox M, Kane J, Mngadi S, Manganye P, Long LC, Metz K, Allen T, Sardana S, Greener R, Zheng A, Thea DM, Murray LK. Study protocol: A randomised trial of the effectiveness of the Common Elements Treatment Approach (CETA) for improving HIV treatment outcomes among women experiencing intimate partner violence in South Africa. BMJ Open. 2022 Dec 22; 12(12):e065848. PMID: 36549749.
- Published on 12/1/2022
Chetty-Makkan CM, Thirumurthy H, Bair EF, Bokolo S, Day C, Wapenaar K, Werner J, Long L, Maughan-Brown B, Miot J, Pascoe SJS, Buttenheim AM. Quasi-experimental evaluation of a financial incentive for first-dose COVID-19 vaccination among adults aged =60 years in South Africa. BMJ Glob Health. 2022 Dec; 7(12). PMID: 36543383.
- Published on 11/3/2022
Guthrie T, Muheki C, Rosen S, Kanoowe S, Lagony S, Greener R, Miot J, Balidawa H, Kiggundu J, Calnan J, Dejene S, Xulu T, Sigwebela N, Long LC. Similar costs and outcomes for differentiated service delivery models for HIV treatment in Uganda. BMC Health Serv Res. 2022 Nov 03; 22(1):1315. PMID: 36329450.
- Published on 11/2/2022
Hendrickson C, Long L, Rensburg C, Claassen C, Njelesani M, Moyo C, Mulenga L, O’Bra H, Russell CA, Nichols BE. The early-stage comprehensive costs of routine PrEP implementation and scale-up in Zambia. PLoS Global Public Health. 2022; 2(11):e0001246.
- Published on 11/2/2022
Hendrickson C, Long LC, van Rensburg C, Claassen CW, Njelesani M, Moyo C, Mulenga L, O'Bra H, Russell CA, Nichols BE. The early-stage comprehensive costs of routine PrEP implementation and scale-up in Zambia. PLOS Glob Public Health. 2022; 2(11):e0001246. PMID: 36962684.
News & In the Media
- Published on August 19, 2022
- Published on April 30, 2021
- Published on April 10, 2020
- Published on November 13, 2017
- Published on September 12, 2017